Rimma Driscoll

Executive Vice President, Global Strategy, Portfolio Marketing, Business Development, Human Health and Platinum Performance · Zoetis

Animal Health

Rimma Driscoll leads strategy, portfolio marketing and business development at Zoetis, with commercial oversight of human health and Platinum Performance.

Last reviewed: Nov 2, 2026

Rimma Driscoll

Executive Vice President, Global Strategy, Portfolio Marketing, Business Development, Human Health and Platinum Performance
Zoetis

Last Reviewed: November 2, 2026

Executive Summary

Rimma Driscoll leads strategy, portfolio marketing and business development at Zoetis, with commercial oversight of human health and Platinum Performance.

Career Highlights

  • Joined Zoetis in 2016 and advanced to executive leadership in 2022.
  • Previously led business development and alliances across Procter & Gamble businesses.
  • Serves on the Dexcom and Pumpkin Insurance boards.

Professional Journey

Driscoll spent more than two decades at Procter & Gamble, building experience in acquisitions, alliances, joint ventures, partnerships and divestitures. Her assignments covered pharmaceuticals, consumer healthcare, beauty care and new business ventures. From 2012 to 2016, she was executive global head for Europe in corporate global business development, establishing and leading a business development group in Geneva.

She joined Zoetis in 2016 as vice president of business development and strategic alliances. In 2020, she advanced to senior vice president, adding business integration to her global business development and alliances responsibilities.

Driscoll became a member of Zoetis’ executive leadership team in 2022. Her work has combined enterprise strategy, commercial launch planning, acquisition execution and integration. Her historical portfolio also included the Global BioDevices business.

Her current responsibilities encompass global strategy, portfolio marketing, business development, integration, external innovation, strategic alliances and medical affairs. She also oversees the human health and Platinum Performance commercial businesses.

In August 2023, she joined the Dexcom board, bringing experience in corporate strategy and healthcare partnerships to the glucose monitoring company. She also serves on the board of Pumpkin Insurance, a pet insurance and preventive care business in which Zoetis holds a minority interest.